IRIS
MOSCHESE, VIVIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 253
AS - Asia 126
EU - Europa 123
AF - Africa 14
Totale 516
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 250
SG - Singapore 55
IT - Italia 54
DE - Germania 49
VN - Vietnam 36
CN - Cina 27
CI - Costa d'Avorio 14
NL - Olanda 7
FI - Finlandia 5
IN - India 4
CA - Canada 3
HK - Hong Kong 3
SE - Svezia 2
BE - Belgio 1
CH - Svizzera 1
GB - Regno Unito 1
PH - Filippine 1
RO - Romania 1
RU - Federazione Russa 1
UA - Ucraina 1
Totale 516
Salva come PNG Salva come JPEG
Città #
Chandler 71
Singapore 50
Dong Ket 36
Santa Clara 27
Des Moines 10
Ashburn 8
Boston 8
Lawrence 8
Nanjing 8
Napoli 8
Beijing 5
Schoenwalde 5
Chennai 4
Helsinki 4
Falls Church 3
Hong Kong 3
Millbury 3
Montesarchio 3
Princeton 3
Redwood City 3
Rietheim-Weilheim 3
Rome 3
Wilmington 3
Woodbridge 3
Amsterdam 2
Fairfield 2
Falkenstein 2
Freiburg im Breisgau 2
Hebei 2
Houston 2
Krefeld 2
Los Angeles 2
Milan 2
Bad Durrheim 1
Brussels 1
Casapulla 1
Cesena 1
Changsha 1
Chengdu 1
Cologne 1
Coquitlam 1
Dallas 1
Duino-Aurisina 1
Gesualdo 1
Ghedi 1
Guangzhou 1
Hanover 1
Harbin 1
Lappeenranta 1
Lissone 1
Mercato San Severino 1
Mississauga 1
Nanchang 1
Nola 1
Ottawa 1
Rimini 1
San Mateo 1
Seattle 1
Shenyang 1
Tianjin 1
Wuxi 1
Totale 328
Salva come PNG Salva come JPEG
Nome #
Clinical, Immunological, and Functional Characterization of Six Patients with Very High IgM Levels 66
Subcutaneous Immunoglobulin Twenty Percent Every Two Weeks in Pediatric Patients with Primary Immunodeficiencies: Subcohort Analysis of the IBIS Study 48
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study 47
Follow-up and outcome of symptomatic partial or absolute IgA deficiency in children 43
X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the world 40
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality 39
Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity 37
Biweekly Hizentra® in Primary Immunodeficiency: a Multicenter, Observational Cohort Study (IBIS) 36
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years 35
Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies 33
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic 31
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 30
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019) 30
The Inborn Errors of Immunity—Virtual Consultation System Platform in Service for the Italian Primary Immunodeficiency Network: Results from the Validation Phase 19
Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET) 15
Totale 549
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.963
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 1 1 2 8 7 3
2020/202167 4 0 1 4 6 0 6 0 1 1 5 39
2021/202267 0 0 1 3 3 5 1 0 0 6 24 24
2022/2023146 13 14 7 9 21 14 0 10 14 2 12 30
2023/202482 3 12 26 5 0 2 1 17 2 2 5 7
2024/2025124 27 27 6 6 30 28 0 0 0 0 0 0
Totale 549